Single Oral Dose Toxicity Study of Aqueous Extracts of Binso-san in ICR Mice
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Although BinSo-San(BSS), a mixed herbal formula consisted of 11 types of medicinal herbs and have been used as anti-inflammatory agent, In the present study, the acute toxicity (single oral dose toxicity) of lyophilized BSS aqueous extracts was monitored in male and female mice after oral administration according to Korea Food and Drug Administration (KFDA) Guidelines (2005-60, 2005). In order to observe the 50% lethal dose (LD50), approximate lethal dosage (ALD), maximum tolerance dosage (MTD) and target organs, test articles were once orally administered to female and male ICR mice at dose levels of 2000, 1000, 500, 250 and 0 (control) mg/kg (body wt.) according to the recommendation of KFDA Guidelines (2005-60, 2005). The mortality and changes on body weight, clinical signs and gross observation were monitored during 14 days after dosing according to KFDA Guidelines (2005-60, 2005) with organ weight and histopathology of 12 types of principle organs. We could not find any mortality, clinical signs and changes in the body weights except for dose-independent increases of body weight and gains restricted in 1000 mg/kg of BSS extracts-dosing female group. Hypertrophic changes of lymphoid organs–thymus, spleen and popliteal lymph nodes were detectedat postmortem observation with BSS extracts dose-dependent increases of lymphoid organ weights, and hyperplasia of lymphoid cells in these all three lymphoid organs at histopathological observations. These changes are considered as results of pharmacological effects of BSS extracts or their components, immunomodulating effects, not toxicological signs. In addition, some sporadic accidental findings such as congestion spots, cyst formation in kidney, atrophy of thymus and spleen with depletion of lymphoid cells, and edematous changes of uterus with desquamation of uterus mucosa as estrus cycles were detected throughout the whole experimental groups including both male and female vehicle controls. The significant (p<0.01) increases of absolute weights of kidney and pancreas detected in BSS extracts 1000 mg/kg-treated female group are considered as secondary changes from increases of body weights. The results obtained in this study suggest that the BSS extract is non-toxic in mice and is therefore likely to be safe for clinical use. The LD50 and ALD of BSS aqueous extracts in both female and male mice were considered as over 2000 mg/kg because no mortalities were detected upto 2000 mg/kg that was the highest dose recommended by KFDA and OECD. In addition, the MTD of BSS extracts was also considered as over 2000 mg/kg because no BSS extracts-treatment related toxicological signs were detected at histopathological observation except for BSS or their component-related pharmacological effects, the immunomodulating effects detected in the present study.
Abstract
Although BinSo-San(BSS), a mixed herbal formula consisted of 11 types of medicinal herbs and have been used as anti-inflammatory agent, In the present study, the acute toxicity (single oral dose toxicity) of lyophilized BSS aqueous extracts was monitored in male and female mice after oral administration according to Korea Food and Drug Administration (KFDA) Guidelines (2005-60, 2005). In order to observe the 50% lethal dose (LD50), approximate lethal dosage (ALD), maximum tolerance dosage (MTD) and target organs, test articles were once orally administered to female and male ICR mice at dose levels of 2000, 1000, 500, 250 and 0 (control) mg/kg (body wt.) according to the recommendation of KFDA Guidelines (2005-60, 2005). The mortality and changes on body weight, clinical signs and gross observation were monitored during 14 days after dosing according to KFDA Guidelines (2005-60, 2005) with organ weight and histopathology of 12 types of principle organs. We could not find any mortality, clinical signs and changes in the body weights except for dose-independent increases of body weight and gains restricted in 1000 mg/kg of BSS extracts-dosing female group. Hypertrophic changes of lymphoid organs–thymus, spleen and popliteal lymph nodes were detectedat postmortem observation with BSS extracts dose-dependent increases of lymphoid organ weights, and hyperplasia of lymphoid cells in these all three lymphoid organs at histopathological observations. These changes are considered as results of pharmacological effects of BSS extracts or their components, immunomodulating effects, not toxicological signs. In addition, some sporadic accidental findings such as congestion spots, cyst formation in kidney, atrophy of thymus and spleen with depletion of lymphoid cells, and edematous changes of uterus with desquamation of uterus mucosa as estrus cycles were detected throughout the whole experimental groups including both male and female vehicle controls. The significant (p<0.01) increases of absolute weights of kidney and pancreas detected in BSS extracts 1000 mg/kg-treated female group are considered as secondary changes from increases of body weights. The results obtained in this study suggest that the BSS extract is non-toxic in mice and is therefore likely to be safe for clinical use. The LD50 and ALD of BSS aqueous extracts in both female and male mice were considered as over 2000 mg/kg because no mortalities were detected upto 2000 mg/kg that was the highest dose recommended by KFDA and OECD. In addition, the MTD of BSS extracts was also considered as over 2000 mg/kg because no BSS extracts-treatment related toxicological signs were detected at histopathological observation except for BSS or their component-related pharmacological effects, the immunomodulating effects detected in the present study.
참고문헌 (34)
- 이지은, "반하의 4주 반복투여독성 평가", Laboratory Animal Research, 19(3), pp.127~141 (2003), 한국실험동물학회
- Ramprasath, V.R, "Evaluation of antioxidant effect of Semecarpus anacardium Linn. nut extract on the components of immune system in adjuvant arthritis", Vascul Pharmacol, 42, pp.179~186 (2005)
- Park, W.D, "Study on the analgesic and anti-inflammatory effects of "Bingso-San "and " Kamibingso-San "", Korean J Pharmacog, 14, pp.24~29 (1983)
- Korea Food and Drug Administration, "Testing Guidelines for Safety Evaluation of Drugs", ~ (2005), Notification No. 2005-2060, issued by the Korea Food and Drug Administration on October
- Organization for Economic Co-Operation and Development, "OECD guideline(401) for testing of chemicals, acute oral toxicity(deleted 2002)", ~ (1987)
- Organization for Economic Co-Operation and Development, "OECD guideline(423) for testing of chemicals acute oral toxicity-acute toxic class method", ~ (2001)
- Irwin, S, "Comprehensive observational assessment: Ia. A systemic, quantitative procedure for assessing the behavioral and physiological state of the mouse", Psychopharmacology, 13, pp.222~257 (1968)
- Dourish, C.T, "Effects of drugs on spontaneous motor activity. In Experimental Psychopharmacology", pp.325~334 (1987), Humana Press
- Heo Jun, "The Presious Mirror of Oriental Medicine", pp.778~780 (1999), Beobin culture Co
- Li Chan, "Elementary Course for Medicine", pp.392~ (1988), Namsandang
- Yun Gil Yeong, "Clinical Prescriptionology in Oriental Medicine", pp.155~ (2002), Hanseong Co
- Zhu, Y.P, "Chinese Materia Medica Chemistry, Pharmacology and Applications. Harwood Academic Publisher", The Netherlands, pp.384~386 (1988)
- Ueda, H, "Luteolin as an anti-inflammatory and anti-allergic constituent of Perilla frutescens", Biol Pharm Bull, 25, pp.1197~1202 (2002)
- Makino, T, "Effect of oral treatment of Perilla frutescens and its constituents on type-I allergy in mice", Biol Pharm Bull, 24, pp.1206~1209 (2001)
- Lee, N.K, "Antiallergic activity of hesperidin is activated by intestinal microflora", Pharmacology, 71, pp.174~180 (2004)
- Chen, Q, "Effects and mechanisms of glucosides of Chaenomeles speciosa on collagen-induced arthritis in rats", Int Immunopharmacol, 3, pp.593~608 (2003)
- Dai, M, "Glucosides of Chaenomeles speciosa remit rat adjuvant arthritis by inhibiting synoviocyte activities", Acta Pharmacol Sin, 24, pp.1161~1166 (2003)
- Zschocke, S, "5-Lipoxygenase and cyclooxygenase inhibitory active constituents from Qianghuo(Notopterygium incisum)", Planta Med, 63, pp.203~206 (1997)
- Okuyama, E, "Analgesic component of Notopterygium incisum Ting", Chem Pharm Bull, 41, pp.926~929 (1993)
- Lu, T, "The research on analgesic and anti-inflammatory action of different processed products of Achyranthes bidentata", Zhong Yao Cai, 20, pp.507~509 (1997)
- Amagaya, S, "Comparative studies of the stereoisomers of glycyrrhetinic acid on anti-inflammatory activities", J Pharmacobiodyn, 7, pp.923~928 (1984)
- Kiuchi, F, "Inhibitors of prostaglandin biosynthesis from ginger", Chem Pharm Bull, 30, pp.754~757 (1982)
- Plata, E.J, "Growth and haematologic properties of the BALB", wm strain of inbred mice, 1972, pp.22, 712~720
- Yamaguchi, C, "Effects of room temperature on reproduction, body weight and organ weights, food and water intakes, and hematology in mice", Exp Anim, 32, pp.1~11 (1983)
- JaeHyun Lee, "Single Subcutaneous Dose Toxicity of Polycan？, a β-Glucan Originated from Aureobasidium in Mice", Laboratory Animal Research, 21(4), pp.299~305 (2005), 한국실험동물학회
- Xiang, D.B, "Antitumor activity and immuno-potentiating actions of Achyranthes bidentata polysaccharides", Zhongguo Yao Li Xue Bao, a14, pp.556~561 (1993)
- Xiang, D.B, "Effects of Achyranthes bidentata polysaccharides on interleukin-1 and tumor necrosis factor-alpha production from mouse peritoneal macrophages", Zhongguo Yao Li Xue Bao, b14, pp.332~336 (1993)
- Yu, S, "Effect of Achyranthes bidentata polysaccharides(ABP) on antitumor activity and immune function of S180-bearing mice", Zhonghua Zhong Liu Za Zhi, 17, pp.275~278 (1995)
- Li, Z.K, "The immunomodulatory effect of Achyranthes bidentata polysaccharides", Yao Xue Xue Bao, 32, pp.881~887 (1997)
- Klein, H.O, "Preclinical and early clinical trial with mafosfamide as immune modulator", Methods Find Exp Clin Pharmacol, pp.9627~9640 (1987)
- Iqbal, M.P, "Folinic acid protects against suppression of growth by methotrexate in mice", Biopharm Drug Dispos, 22, pp.169~178 (2001)
- Hyeung-Sik Lee, "Single Oral Dose Toxicity Study of Water Extractsof Picrorrhiza Rhizoma In ICR Mice", 한국독성학회지, 22(2), pp.117~126 (2006), 한국독성학회
- Hodge, H.C, "Tabulation of toxicity classes", Am Ind Hyg Q, 10, pp.93~ (1949)
- U.S. Environmental Protection Agency, "Health Effects Test Guidelines OPPTS 870.100, Acute Toxicity Testing Background" (1998), US EPA August